Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system.

Cell replacement therapy using mesencephalic precursor cells is an experimental approach for the treatment of Parkinson's disease (PD). A significant problem associated with this procedure is the poor survival of…

Continue ReadingCreatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system.